TVTX Cost of Revenue
Travere Therapeutics Inc · Cost of Revenue
TVTX Cost of Revenue
Latest reported$33.08Mperiod ending
TVTX Cost of Revenue ($0.00 → $33.08M)
Annual cost of revenue
High-resolution chart · PNG
TVTX cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 10,339,000 | |
| 7,744,000 | |
| 11,450,000 | |
| 4,420,000 | |
| 3,818,000 | |
| 6,126,000 | |
| 5,234,000 | |
| 5,527,000 | |
| 3,605,000 | |
| 4,554,000 | |
| 2,185,000 | |
| 570,979 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |